Copyright
©The Author(s) 2021.
World J Gastroenterol. Jul 14, 2021; 27(26): 4208-4220
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4208
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4208
Figure 4 Effects of norcantharidin-loaded metal-organic framework IRMOF-3 coated with temperature-sensitive gel on the cell cycle.
The percentage of total cells in S and G2/M phases increased significantly with increasing norcantharidin (NCTD)-loaded metal-organic framework IRMOF-3 coated with temperature-sensitive gel (NCTD-IRMOF-3-Gel) concentration, and the proportion of cells in G0/G1 phase decreased significantly. A: Control group; B: 10 μg/mL; C: 20 μg/mL; D: 40 μg/mL. G1 phase: DNA presynthetic phase, where mitosis is complete before DNA replication begins; G2 phase: DNA synthesis replication phase, where DNA replication is complete before mitosis begins; M phase: Cell division phase; S phase: DNA synthesis replication phase.
- Citation: Li XY, Guan QX, Shang YZ, Wang YH, Lv SW, Yang ZX, Wang R, Feng YF, Li WN, Li YJ. Metal-organic framework IRMOFs coated with a temperature-sensitive gel delivering norcantharidin to treat liver cancer. World J Gastroenterol 2021; 27(26): 4208-4220
- URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4208.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4208